Figures & data
Table 1. Baseline characteristics of the first 100 patients of the ESO-SPARE trial.
Figure 1. Overall survival in respondents and nonrespondents of PROMs in the first 100 patients of the ESO-SPARE trial.
![Figure 1. Overall survival in respondents and nonrespondents of PROMs in the first 100 patients of the ESO-SPARE trial.](/cms/asset/f8f5c4c4-83c0-47d0-8d50-6187094833e3/ionc_a_2251083_f0001_c.jpg)
Table 2. Dosimetry parameters of the first 100 patients in the ESO-SPARE trial.
Supplemental Material
Download MS Word (25.1 KB)Supplemental Material
Download MS Word (15 KB)Data availability statement
The data that support the findings of this study are not openly available due to reasons of sensitivity and are available from the corresponding author, AMN, upon reasonable request, after the termination of the ESO-SPARE trial.